Advanced thyroid cancer responds to targeted therapy with sunitinib

| March 8, 2015 | 0 Comments

In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found.

Continue Reading:
Advanced thyroid cancer responds to targeted therapy with sunitinib

Tags: , , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply